Drug intelligence / Profile preview

All-Vent

Development stage
Unknown
Lead developer
Borg Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

All-Vent is a combination respiratory medication developed and manufactured by Borg Pharmaceutical Industries. It is formulated as an oral syrup containing four active ingredients: bromhexine hydrochloride, terbutaline sulphate, guaifenesin, and menthol. Terbutaline acts as a bronchodilator by stimulating beta-2 adrenergic receptors, leading to relaxation of bronchial smooth muscle and improved airflow. Bromhexine serves as a mucolytic agent that reduces the viscosity of bronchial secretions by fragmenting mucopolysaccharide fibers, while guaifenesin acts as an expectorant to increase the volume and reduce the stickiness of respiratory tract secretions, facilitating their removal. Menthol is included for its soothing effect on the respiratory mucosa. All-Vent is primarily indicated for the relief of productive cough associated with bronchospasm in conditions such as bronchial asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and emphysema. The syrup is sugar-free and dye-free, making it suitable for use in diabetic patients.

Brand names
All-Vent
Other names
Bromhexine + Terbutaline + Guaifenesin + Menthol
02

Targets

ADRB2 (β2)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on All-Vent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on All-Vent.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call